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Phospholipid membranethe hepatitis B virus (HBV) envelope proteins in the ﬁrst steps of viral infection
has been restricted to their implication in virus attachment to a putative hepatocyte receptor. In order to
explore a fusion activity in these regions, we used recombinant preS domains to characterize their
interaction with liposomes. Binding experiments carried out with NBD-labeled proteins indicated that preS
were able to interact in a monomeric way with acidic phospholipid vesicles, being the partition coefﬁcient
similar to that described for peptides which can insert deeply into bilayers. Fluorescence depolarization of
DPH-labeled vesicles conﬁrmed the speciﬁcity for negative charged phospholipids. Upon interaction the
proteins induced aggregation, lipid mixing and release of internal contents of acidic vesicles at both acid and
neutral pH in a concentration-dependent manner. Taken together, all these data indicate that preS domains
are able to insert into the hydrophobic core of the bilayer. Moreover, the insertion resulted in a protein
conformational change which increased the helical content. Therefore all these results suggest that, besides
their participation in the recognition of a cellular receptor, the preS domains could be involved in the fusion
mechanism of HBV with the plasma membrane of target cells.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Hepatitis B virus (HBV) is a small enveloped DNAvirus that belongs
to the hepadnaviridae family. It causes persistent infection of
hepatocytes, resulting in some cases in the development of chronic
hepatitis and hepatocellular carcinoma. Despite representing a
worldwide health problem, the mechanisms of attachment and
entry of HBV into target cells are still poorly understood.
The envelope proteins of HBV are assumed to play key roles in the
binding and fusion of target cells. The virus possesses three surface
proteins known as small (S), medium (M) and large (L) that are
translated from a single open reading frame at three different
translational start codons. Thus, all three proteins share 226 amino
acids (the complete S protein) at the carboxy-terminus; the M protein
possesses an extension of 55 amino acids, termed as preS2 region, at
the N-terminus of S protein, while the L protein is composed of the
entire M protein prolonged at the N-terminus by the preS1 region,
which consists of 108 in the HBV subtype known as ayw or 119
residues in the other threemain subtypes adw, ayr and adr (Fig.1). The34 91 394 41 59.
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l rights reserved.preS1 and preS2 regions, known together as preS domains, have been
implicated in the binding of the virus to hepatocytes [1, 2]. Several
receptors for HBV have been proposed to interact with different
regions of preS domains [3, 4] although none of them have been
proven to function in viral entry. Nowadays a generally accepted view
is the involvement of preS1 in attachment to hepatocytes, being the
viral entry activity of this region solely dependent on the integrity of
its ﬁrst 75 amino acids [5]. Moreover, recent studies suggested that
lipoprotein lipase (LPL) may play a role in the initiation of HBV
infection via interaction with the N-terminal part of preS1 [6].
Regarding the role of HBV envelope proteins in the fusion step, a
putative fusion peptide sequence of 16 amino acids at the N-terminus
of S protein has been described [7]. A synthetic peptide comprising
this predicted fusion region was shown to interact with model
membranes, promoting liposome destabilization in a pH-dependent
manner [8], and adopting an extended conformation during the
process [9]. Evidence for the role of the N-terminal S peptide in fusion
has been obtained after treatment of HBV virions with V8 protease, an
enzyme that cleaves the S sequence at position 2, removing the preS
domains and exposing the hydrophobic fusion peptide; intact HBV
hardly infected HepG2 cells, but V8 protease-digested HBV particles
efﬁciently infected and proliferated in these human hepatoblastoma
cell lines [10]. The destabilization properties observed for the HBV
fusion peptide can be extended to other members of the hepadnavirus
family, as demonstrated using oligopeptides corresponding to the N-
terminal portion of duck and woodchuck hepatitis B viruses (DHBV
Fig. 1. Schematic representation of HBV Large surface protein and preS domains. (A) The S, preS1 and preS2 domains are depicted. The position of the putative fusion peptide (FP), at
the N-terminal of S region, is also indicated. (B) The amino acid sequence of the N and C-terminal regions of adw and ayw preS domains are showed. The 6xHis at the C-terminal
indicates the position of the His tag added to the amino acid sequence.
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particles induced infectivity towards human HepG2 cells [12],
conﬁrming that the exposure of this consensus fusion motif is
important in hepadnavirus entry.
Despite their location at the surface of natural virions, the preS
domains have never been directly involved in the fusion process,
being their role in viral entry only associated with the attachment of
HBV particles to possible cellular receptors. With the aim to explore
the fusogenic capabilities of these regions, two recombinant preS
domains from adw and ayw subtypes, produced in E. coli cells as
previously described [13], were used inmembrane interaction studies.
In this paper we describe that preS domains are able to interact with
acidic phospholipid vesicles and to destabilize thesemembranemodel
systems, and hence, could contribute, together with the N-terminal S
peptide, to the fusion of viral and cellular membranes.
2. Materials and methods
2.1. Reagents
N-(7-nitro-2,1,3-benzoxadiazol-4-yl)-dimyristoylphosphatidy-
lethanolamine (NBD-PE), N-(lissamine rhodamine B sulfonyl)-diacyl-
phosphatidylethanolamine (Rh-PE), egg phosphatidylglycerol (PG),
and dimyristoylphosphatidylglycerol (DMPG) were provided by
Avanti Polar Lipids. 8-Aminonaphtalene-1,3,6-trisulfonic acid
(ANTS), p-xylenebis(pyridinium) bromide (DPX) and 1,6-diphenyl-
1,3,5-hexatriene (DPH) and 4-ﬂuoro-7-nitrobenz-2-oxa-1,3-diazole
(NBD-F) were purchased from Molecular Probes. Triton X-100 was
purchased from Boehringer Mannheim. All other reagents were
obtained from Merck and Sigma. All solvents were of HPLC grade.
2.2. Cloning, expression, puriﬁcation and labeling of preS domains
The cDNAs coding for preS domains of subtypes adw and aywwere
cloned as described previously in expression vectors that add six-
histidine sequences at the carboxy-terminal end of each protein [13].
E. coli strains BL21 (DE3) and HMS174 (DE3) were transformed with
the recombinant plasmids pT7-7-preS-his-adw and pET-3d-preS-his-
ayw respectively and isopropyl -D-thiogalactopiranosyde (IPTG) was
added to a ﬁnal concentration of 0.5 mM to induce protein expression.
Both recombinant proteins were puriﬁed using a single afﬁnity-
chromatography step in Sepharose CL-6B Ni-nitrilotriacetic acid (NTA)
column (Qiagen), following procedures previously described, giving
rise to highly pure and stable 20–25 mg of preS-his-ayw and 35–
40 mg of preS-his-adw from 1 L of culture media [13].
Fluorescent labeling of the N-terminus of the proteins was
achieved following the procedure described by Rapaport and Shai
[14]. Brieﬂy, preS proteins were incubated at pH 6.8 with a ten molar
excess of NBD-F for 4 h at room temperature. Unbound NBD-F was
removed by means of a PD-10 column. The labeling of the protein
could be monitored by the appearance of a maximum at 467 in theabsorbance spectrum, which was used to determine the labeling ratio.
The NBD and protein concentrations were determined by using
20,000 M−1 cm−1 as the molar extinction coefﬁcient of NBD-PE and
amino acid analysis, respectively.
2.3. Vesicle preparation
In all cases a lipid ﬁlm was obtained by drying a chloroform:
methanol (2:1) solution of the lipid under a current of nitrogen and
this ﬁlm was further kept under vacuum for 4–5 h to completely
remove the organic solvent. The phospholipids were resuspended at a
concentration of 1mg/ml inmedium buffer (100mMNaCl, 5mMMES,
5 mM sodium citrate, 5 mM Tris, 1 mM EDTA) at the appropriate pH
value and incubated for 1 h at 37 °C and eventually vigorously
vortexed. This suspension was sonicated in a bath sonicator (Branson
1200) and was subsequently subjected to nineteen cycles of extrusion
in a Liposo Fast-Basic extruder apparatus (Avestin, Inc.) with 100-nm
polycarbonate ﬁlters (Costar). When encapsulation was required, an
additional step of ﬁve freeze-thawing cycles was included after the
sonication process.
2.4. Binding experiments
Binding experiments were conducted as previously described [14].
In order to determine the degree of NBD-preS-his association with
phospholipid vesicles, PC or PG vesicles were added to a ﬁxed amount
of labeled protein (0.15 μM) in medium buffer at the desired pH and
incubated at 37 °C. The ﬂuorescence intensity at different lipid/protein
molar ratios was registered in a SLM AMINCO 8000C spectro-
ﬂuorimeter (SLM Instruments), with excitation and emission wave-
lengths set at 468 and 530 nm, respectively. In all cases, ﬂuorescence
from control vesicles in the absence of labeled proteinwas subtracted.
In order to obtain the partition coefﬁcient, data were analyzed using
the equation [14, 15]:
Xb = Kpd Cf
where Xb is the molar ratio of bound protein per total lipid, Kp
corresponds to the partition coefﬁcient and Cf represents the
equilibrium concentration of free protein in solution. It was assumed
that proteins only partitioned over the outer leaﬂet of vesicles.
Therefore, Xb values were corrected as Xb⁎=Xb /0.6 and the data
analyzed as:
X4b = K
4
pd Cf
Values of the corrected partition coefﬁcient, Kp⁎, were determined
from the initial slopes of the binding isotherms.
In order to calculate Xb, we estimated F∞, the ﬂuorescence signal
obtained with a saturating phospholipid concentration by extrapolat-
ing from a double reciprocal plot of F (total protein ﬂuorescence)
versus CL (total lipid concentration). At every phospholipid
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formula:
fb = F−F0ð Þ= F∞−F0ð Þ
where F0 represents the ﬂuorescence of unbound protein and F∞ the
ﬂuorescence of bound protein.
2.5. Fluorescence polarization
Fluorescence polarizationmeasurements of the probe 1,6-diphenyl-
1,3,5-hexatriene (DPH) were taken in the SLM AMINCO 8000C
spectroﬂuorimeter by using 10 mm Glan-Thompson polarizers. DMPG
and DMPC vesicles (0.14 mM) were prepared as indicated above
containing DPH at aweight ratio of 1:500. The protein-vesiclemixtures
were incubated for 30min at 37 °C and then cooled. The excitationwas
set at 365 nmandemissionwasmeasured at 425nm, after equilibration
of the samples at the indicated temperature. The temperature in the
cuvette was maintained with a circulating water bath.
2.6. Vesicle aggregation
The increase in the optical density at 360 nm ( OD360) produced by
addition of preS proteins to a phospholipid vesicle suspension, in
medium buffer at the appropriated pH, was measured on a Beckman
DU-7 spectrophotometer after incubation for 1 h at 37 °C. Values of
control samples containing only vesicles and only protein were
subtracted at each protein concentration. The ﬁnal phospholipid
concentration was kept at 0.14 mM.
2.7. Release of aqueous contents
Leakage was determined by the ANTS/DPX assay [16], which is
based on the dequenching of ANTS ﬂuorescence caused by its dilution
upon release of the aqueous contents of one vesicle preparation
containing both ANTS and DPX. It was performed by coencapsulating
12.5 mM ANTS and 45 mM DPX in 10 mM Tris, 20 mM NaCl, pH 7.2, in
phospholipid vesicles. The lipid ﬁlm was hydrated as described
previously and the vesicles were sonicated 30 min. Afterwards the
vesicles were subjected to ﬁve cycles of freeze-thawing in liquid
nitrogen an passed 15 times through a Liposo Fast-Basic extruder
apparatus (Avestin, Inc.) with 100-nm polycarbonate ﬁlters (Costar).
After the vesicles with the coencapsulated probe and quencher were
formed, the whole sample was passed through a Sephadex G-75
column (Pharmacia) to separate the vesicles from the non encapsu-
lated material using medium buffer for elution. Assays were
performed inmedium buffer at the appropriated pH, at a phospholipid
concentration of 0.1–0.14 mM in medium buffer at the appropriated
pH by incubating with different amounts of proteins for 1 h at 37 °C
and measuring in the SLM Aminco 8000C spectroﬂuorimeter. The
excitation wavelength was set at 385 nm and the ANTS emission was
monitored at 520 nm. Both the excitation and emission slits were set
at 4 mm. The excitation and emission polarizers were kept constant at
90° and 0°, respectively, to minimize interference due to dispersion.
The ﬂuorescence scale was set to 100% by addition of 0.5% Triton X-
100, and 0% leakage was obtained measuring the ﬂuorescence of
control vesicles without protein.
2.8. Lipid mixing assay
Lipid mixing was monitored by using the classical ﬂuorescent
probe dilution assay [17], inwhich the decrease in the efﬁciency of the
ﬂuorescence energy transfer between NBD-PE (energy donor) and Rh-
PE (energy acceptor) incorporated into liposomes, as a consequence of
lipid mixing, is measured. Liposomes, in medium buffer at the
appropriated pH, labeled with 1 mol% NBD-PE and 1 mol% Rh-PEwere mixed with unlabeled liposomes in a 1:9 molar ratio. After
incubation of liposomes with the preS domains at different concen-
trations for 1 h at 37 °C, emission spectra were recorded with the
excitationwavelength set at 450 nm. Both the excitation and emission
slits were set at 4 mm. The excitation polarizer was kept constant at
90° and the emission polarizer was kept constant at 0° to minimize
dispersive interference. The efﬁciency of the energy transfer was
calculated from the ratio of the emission intensities at 530 and 590 nm
and the appropriated calibration curve. The ﬁnal phospholipid
concentration was 0.14 mM. The organic solvent itself had no effect
on the efﬁciency of the energy transfer.
2.9. Electron microscopy
Samples of egg PG vesicles (obtained by extrusion through a
0.1 mm pore diameter polycarbonate ﬁlter) were incubated with preS
proteins at different lipid and protein concentrations for 1 h at 37 °C.
Subsequently, the lipid–protein mixtures were applied to a glow-
discharged 400-mesh Formvar-carbon-coated grid for 2 min. Grids
werewashedwith deionized water and with PBS, and excess ﬂuid was
drawn away with ﬁlter paper. Samples were then negatively stained
for 5 minwith 2% phosphotungstic acid at pH 7.0 and examined under
a Zeiss EM 902 (Jena, Germany) transmission electron microscope
operating at 80 kV.
2.10. Circular dichroism
CD measurements were carried out on a Jasco spectropolarimeter,
model J-715. All themeasurements were carried out at 25 °Cwith cells
thermostated with a Neslab RTE-111 water bath. The spectra were
taken in medium buffer at the desired pH and at a protein
concentration of 0.10 mg/ml. The pathlength was 1 mm. Five scans
were averaged for each measurement and the contribution of the
buffer was always subtracted. The spectra were calculated by using
110 as the mean residue molecular mass and the results are expressed
in terms of residue molar ellipticity in deg cm2 dmol−1. The secondary
structure of the protein was evaluated by computer ﬁt of the
dichroism spectra according to Convex Constraint Analysis (CCA)
[18]. This method relies on an algorithm that calculates the
contribution of the secondary structure elements that give rise to
the original spectral curve without referring to spectra from model
systems.
3. Results
3.1. Binding studies
The two domains used through this work are representative of all
the HBV subtypes. They have been previously characterized [13]. The
results presented are those obtained with preS domains which have
been tagged with a 6xHis sequence at their C-terminal end (Fig. 1).
However, similar interacting and destabilization properties have been
observed for a preS domain which does not have the His tag. The
reaction of preS domains with NBD-F led to the addition of the NBD
moiety to the polypeptide chain. From the absorbance spectrum it can
be calculated that approximately the proteinwas labeled in a 1:1 ratio.
Taking into account that the reaction was carried out at pH 6.8, it is
likely that the α-amino group, and not the Lys side chains, is the main
labeling target. The NBD ﬂuorophore has been employed in binding
studies since its ﬂuorescence spectrum reﬂects the environment in
which the NBD group is located [14, 19]. Emission spectra of NBD-
labeled preS proteins were recorded in buffer or upon interactionwith
PC or PG Large Unilamellar Vesicles (LUV). The wavelength of the
maximum of the emission spectrum of labeled proteins under these
conditions is shown in Table 1. In solution both proteins exhibited
emission maxima centered at 544 nm, which is consistent with
Table 1
Fluorescence emission maxima of NBD-labeled preS domains in solution or in the
presence of PC and PG vesicles and corrected partition coefﬁcients (Kp⁎) determined
from the initial slopes of the binding isotherms, as indicated in the Materials and
methods section
pH Emission maxima Kp⁎ (M−1)×10−5
Buffer PGh PCh PGh PCh
NBD-preS-his-ayw 7.0 544 522 534 0.1 –
5.0 544 522 534 2.9 0.11
NBD-preS-his-adw 7.0 544 522 534 0.047 –
5.0 544 520 534 3.0 0.036
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Upon interaction with negatively charged phospholipids, and under
saturating conditions to avoid the contribution of the free protein to
the emission spectrum, these maxima were shifted to 522 nm. The
observed blue shift reﬂects a relocation of the NBD group in a more
hydrophobic environment. In the presence of neutral phospholipids
there is a smaller change in the position of the maximum (Table 1)
which could reﬂect a more shallow location of the protein within the
bilayer [14].
In order to calculate the extent of binding, the labeled proteins, at a
ﬁnal concentration of 0.15 μM, were titrated with increasing amounts
of PG or PC vesicles. This protein concentration was low enough to
avoid aggregation of vesicles. Moreover, control experiments were
performed by titrating unlabeled proteins with the same concentra-
tion of vesicles. The measured increase in ﬂuorescence at 530 nm,
after subtracting the contribution of the control samples, was plotted
against the phospholipid concentration (Fig. 2). After incubation with
PGh, there is a signiﬁcant increase in ﬂuorescence intensity either at
pH 7.0 or pH 5.0 (Fig. 2), although the effect is higher at acidic pH.
From these data binding isotherms were obtained (Fig. 2, inset) as
described in Materials andmethods section. The partition coefﬁcients,
reﬂecting the binding constants, were calculated as the slopes of these
lines (Table 1). The values of Kp⁎ determined in the presence of acidic
phospholipids at pH 5.0, 3×105 M−1, were similar to those described
for labeled peptides which insert into phospholipid bilayers [14].
However, as expected from the ﬂuorescence increments, the coefﬁ-
cients obtained at pH 7.0 were two orders of magnitude lower. On the
other hand, when neutral phospholipids were used in these experi-
ments, no increase in F530 values were obtained at pH 7.0 (data notFig. 2. Increase in ﬂuorescence of NBD-preS-his proteins upon titration with PGh
vesicles. Labeled preS-his-ayw (●) and preS-his-adw (○) proteins (0.15 μM)were added
to PGh vesicles at different lipid concentrations in medium buffer at pH 5.0 (A) or 7.0 (B).
The mixtures were incubated at 37 °C for 2 min and ﬂuorescence intensity was
measured at 530 nm. Insets represent the binding isotherms obtained from the
increments of NBD ﬂuorescence intensities. Values of Xb⁎ and Cf were calculated as
indicated under Materials and methods. The results shown are representative of those
obtained for three different experiments.shown) and thus no partition coefﬁcients could be determined while
at pH 5.0 the calculated Kp⁎were similar to those observed with acidic
phospholipids at neutral pH (Table 1).
3.2. Fluorescence polarization
To ascertain the existence of a hydrophobic component in the
interaction of the preS proteins with acidic and neutral phospholipids,
their effect on the thermotropic behavior of DMPG and DMPC vesicles
has been studied by measuring the ﬂuorescence polarization of these
liposomes labeled in the hydrophobic core of the bilayer with the
ﬂuorescent probe DPH. Fig. 3 shows the ﬂuorescence depolarization of
DPH-labeled DMPG vesicles with increasing temperatures in the
presence of preS-his proteins adw (A, B) or ayw (C, D) at different
protein/phospholipid molar ratios at pH 7.0 (A, C) and 5.0 (B, D). The
addition of preS-his proteins to DMPG vesicles induced a decrease in
the amplitude of the transition in a concentration-dependent manner,
without affecting the temperature of the transition. This effect was
observed almost exclusively at temperatures above the transition
temperature, indicating that the proteins affected mainly the acyl
chains in the liquid–crystal phase, inducing a higher order in the chain
packing. At low protein concentrations the effect was slightly higher at
acidic pH. However, when protein concentration increased, the effects
were nearly indistinguishable at both pHs. As observed in all the insets
of Fig. 3, the ﬂuorescence polarization measured at 37 °C increased
linearly up to a protein to lipid ratio of 0.045, remaining constant from
this point. The fact that the amplitude of phase transition was mainly
the only modiﬁed parameter reveals the importance of the hydro-
phobic component in the interaction of preS domains with phospho-
lipids. On the other hand, no effects in the transition curve of DMPC
vesicles were observed (data not shown).
When studies were performed using the ﬂuorescent probe TMA-
DPH, the results obtained were very similar to those described above
for DPH (data not shown).Fig. 3. Temperature dependence of the ﬂuorescence polarization of DPH-labeled DMPG
liposomes. Vesicles were incubatedwith different concentrations of preS-his-adw (A, B)
or preS-his-ayw (C, D) proteins for 30 min at 37 °C in medium buffer at pH 7.0 (A, C) or
5.0 (B, D). After cooling, polarization was measured at the indicated temperature. The
phospholipid concentration was 0.14 mM and the preS/lipid molar ratios employed
were (▴) 0.0, (●) 0.01 and (▪) 0.045. Insets represent ﬂuorescence polarization at 37 °C
as a function of protein/phospholipid ratio. The results shown are representative of
those obtained for three different experiments.
Fig. 5. Lipid mixing (A) and leakage of ANTS/DPX (B) induced by preS proteins. (A)
Increasing concentrations of preS-his-adw (▵) or preS-his-ayw (○) were added to a 1:9
mixture of labeled (NBD-PE 1% and Rh-PE 1%) and unlabeled PG vesicles hydrated in
medium buffer at pH 7.0 (empty symbols) and 5.0 (ﬁlled symbols). The Resonance
Energy Transfer (RET) between NBD-PE and Rh-PE was calculated as indicated in
Materials and methods. (B) Increasing concentrations of preS-his-adw (▵) or preS-his-
ayw (○) were added to egg PG vesicles loaded with ANTS and DPX in medium buffer at
pH 7.0 (empty symbols) and 5.0 (ﬁlled symbols). The mixtures were incubated at 37 °C
for 1 h and the ﬂuorescence intensity was measured at 520 nm. Maxima ﬂuorescence
was obtained upon addition of 0.5% Triton X-100. The results shown are representative
of those obtained for at least three different experiments.
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Vesicle aggregation was monitored by measuring the increment
of the optical density at 360 nm (ΔOD360) of PGh liposomes as a result
of the increase in vesicle size upon incubation with different
concentrations of preS-his proteins. Fig. 4 shows the results obtained
with preS-his adw, being those with preS-his ayw very similar. The
ΔOD360 value increased up to a protein concentration of 6–8 μM and
then remained constant. This effect was observed both at pH 7.0 and
5.0 although ΔOD360 was slightly higher at acidic pH. On the other
hand, when preS-his were incubated with neutral phospholipids, the
increase of OD360 at any pH value was almost negligible (data not
shown).
Vesicle aggregation was also measured at different PG concentra-
tions and maintaining a constant protein to lipid molar ratio of 1:75
(Fig. 4, inset). As it was expected, OD360 augmented almost linearly up
to a lipid concentration of 1.5 mM and remained constant up to
2.0 mM. However, at 2.6 mM PG (34.6 μM of preS-his adw) the optical
density diminished to values even lower than the corresponding
control, indicating a possible disruption of the vesicles. These results
were similar both at pH 7.0 and 5.0 and using either preS-his-adw or
preS-his-ayw.
3.4. Lipid mixing
Mixing of phospholipid vesicles was followed by the decrease in
resonance energy transfer (RET) between the ﬂuorescent probes NBD-
PE and Rh-PE incorporated into a lipid matrix [17], which accurately
reﬂects the degree of fusion [21]. As observed in Fig. 5A preS domains
of both ayw and adw subtypes were able to induce lipid mixing when
using PG vesicles, both at pH 7.0 and 5.0. Although at low protein
concentration the decrease of RET was more pronounced at acidic pH,
the results obtained at both pH values made equal as the protein
concentration was increased. At either pH value %RET decreased from
72, in the absence of protein, to 18–20 at 10 μM preS-his. These values
correspond to a dilution in acceptor surface density of approximatelyFig. 4. Aggregation of egg PG phospholipid vesicles induced by preS-his-adw protein.
The optical density at 360 nm ( ΔOD360) was measured after incubation of vesicles
(0.14 mM) in medium buffer at pH 7.0 (○) and 5.0 (●) with proteins at different
concentrations. Values of control samples containing only PG liposomes were
subtracted. Inset represents the ΔOD360 as a function of PG concentration at a constant
protein/lipid ratio of 1:75 at pH 7.0. The results shown are representative of those
obtained for at least three different experiments.eightfold. Since the mere aggregation of the vesicles would not result
in such a big change in energy transfer [22], it could be concluded that,
under the conditions studied, preS domains induce the complete
fusion of vesicles.
3.5. Release of aqueous contents
The ability of preS proteins to destabilize the lipid bilayer was also
assessed by determining the release of aqueous content of phospho-
lipid vesicles. Liposome leakage was monitored by measuring the
increase in ANTS ﬂuorescence at 520 nm [23]. Fig. 5B shows the
leakage induced by ayw and adw preS-his domains when added to PG
vesicles. Both proteins were able to induce the release of internal
contents of the vesicles in a concentration-dependent manner. The
maximum effect was attained at 0.5–1.0 μM of protein, concentrations
much lower than those needed to induce vesicle aggregation or lipid
mixing (5–10 μM). On the other hand, at low protein concentrations
leakage was slightly higher at acidic pH, being the pH dependence of
the lipid destabilization lower than that observed in the aggregation
and lipid mixing assays. The maximum ﬂuorescence reached with
either protein, 75–85%, is similar to that described for other proteins
and did not attain the value obtainedwhen liposomeswere lysed with
the detergent Triton X-100 (100% leakage).
3.6. Electron microscopy studies
Incubation of preS-his domains with PG liposomes had effects on
the morphology and size of the phospholipid vesicles as can be
observed by electron microscopy after negative staining with sodium
phosphotungstate. Fig. 6 shows the results obtained with PG vesicles
in the presence of preS-his adw at pH 7.0. Fig. 6A indicates that control
PG vesicles had a homogeneous size of 100–130 nm. Addition of
protein at a concentration of 5.3 μM induced aggregation and fusion of
liposomes, leading to the disappearance of the original half moon
typical staining of control PG vesicles that instead adopted large
aggregated structures of 250–420 nm (Fig. 6B). Furthermore, in some
cases interactionwith preS-his protein induced formation of ﬁlaments
(Fig. 6C). When lipid and protein concentrations were increased,
maintaining unchanged the molar ratio, the PG vesicles were
fragmented into smaller, 30–60 nm, particles (Fig. 6D); this observa-
tion is in accordance with the aggregation studies (Fig. 4, inset), and
indicates that the protein was able to induce the vesicle disruption
under these conditions.
Fig. 6. Electron micrographs of egg PG vesicles in the presence of preS-his-adw protein.
PG liposomeswere incubatedwith the protein at pH 7.0 for 1 h at 37 °C and themixtures
were transferred to glow-discharged Formvar-carbon-coated grids. Afterwards, they
were negatively stained with sodium phosphotungstate. (A) Egg PG vesicles (0.14 mM)
in the absence of protein. (B–D) PG-preS mixtures at a 1:75 molar lipid/protein ratio; (B,
C) [PG]=0.4 mM; (D) [PG]=2.65 mM. The bar indicates 150 nm.
Fig. 7. CD spectra of preS-his-adw protein incubated for 1 h at 37 °Cwith egg PG vesicles.
The circular dichroism spectra were recorded both in the absence (▴) and the presence
(●) of egg PG liposomes, at pH 7.0 (A) and 5.0 (B). The protein concentrationwas 0.1 mg/
ml, and the lipid/protein molar ratio was kept at 20:1.
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The interaction and insertion of preS domains into the hydro-
phobic core of phospholipid vesicles brought about a conformational
change which could be assessed by circular dichroism. Thus, Fig. 7
shows the CD spectra of adw preS-his at pH 7.0 (Fig. 7A) and 5.0 (Fig.
7B) both alone and in the presence of egg PG. At either pH, the CD
spectrum of preS domains is characteristic of a protein with a high
content of non-regular structure. However, in the presence of acidic
phospholipids there is an increase in the ellipticity values together
with a shift of the minimum from 200 to 205 nm and the appearance
of a shoulder at 225 nm, characteristic of helical structure. In fact,
deconvolution of CD spectrum by CCA method indicated that the
percentage of helical content increased from 0 to 10% with the
concomitant decrease of non-regular structures. The results obtained
with the ayw subtype were similar (data not shown). However, no
changes in the CD spectrumwere observed in the presence of neutral
phospholipids.
4. Discussion
Based on a previously reported method which relies on the
changes of the ﬂuorescence properties of NBD-labeled peptides or
proteins [14], it can be assessed that preS domains interact with
phospholipid vesicles. The addition of increasing concentrations of
phospholipids to NBD-labeled proteins led to a shift in the
ﬂuorescence emission maximum of NBD as well as to an increase in
the ﬂuorescence intensity at 530 nm. As described for other peptides,
the ﬁrst data gives information about the location of the protein in the
bilayer after the interaction [14]. Thus, in the presence of acidic
phospholipids the maximum was shifted to 520–522 nm, both at pH
7.0 and 5.0, indicating that the NBDwas located in amore hydrophobic
environment, similarly towhat has been described for peptides deeply
inserted into the bilayer (λmax=518–528 nm). However, in thepresence of neutral phospholipids the position of the emission
maximum (λmax=534 nm) was analogous to that observed for
peptides interacting with the bilayer at the surface [14]. On the
other hand, binding isotherms, derived from the increments in
ﬂuorescence intensities, provide information about the mechanism
of the interaction [15, 24]. Thus, the straight lines obtained in all cases
denoted that the proteins interact with the bilayer in a monomeric
form, being unnecessary the formation of oligomers to elicit lipid–
protein interactions. Furthermore, crosslinking experiments with the
bifunctional reagent bis-(sulfosuccinimidyl)suberate indicate that
when preS domains interact with acidic phospholipids no oligomers
of deﬁned structure are formed since only a small fraction of dimers
and trimers is observed (data not shown). On the other hand, the
interaction coefﬁcients were calculated from the slopes of the lines.
Thus, in the presence of acidic phospholipids at pH 5.0 the values
achieved with both preS domains were of the order of magnitude of
those described for peptides having a strong interaction with the
bilayer, such as the transmembrane peptides or even peptides forming
pores in the membrane [14, 19, 25]. However, the constant reached at
pH 7.0 was signiﬁcantly lower, indicating a much lower interaction
between the protein and the phospholipids although NBDwas located
in a similar hydrophobic environment to that at pH 5.0. When neutral
lipids were used no partition coefﬁcients could be calculated at pH 7.0
and the values obtained from the increment in ﬂuorescence
intensities at pH 5.0 were similar to those obtained with PG at pH
7.0. These strong differences observed with both types of phospho-
lipids reveal the importance of electrostatic interactions in the binding
of preS domains to lipid vesicles as expected for two basic proteins
which undergo an increase in positive net charge from 3–5 at pH 7.0 to
12–15 at pH 5.0.
Fluorescence depolarization studies conﬁrmed the above men-
tioned speciﬁcity. The observed decrease of the transition amplitude
together with the maintenance of the transition temperature are
typical effects of integral membrane proteins [26], suggesting that
preS domains are able to insert into the lipid bilayer as a consequence
of their interaction with acidic phospholipids. Moreover, assuming
that the NBD labelingwasmainly produced in the α-amino group, the
amino terminal region of preS domains should, at least, be the area
inserted into the bilayer. When ﬂuorescence depolarization was
plotted against the protein to lipid ratio, a linear increase was
obtained until a relationship of 0.045. This value would indicate that
each molecule of protein prevented an average of 22 phospholipid
molecules to undergo a phase transition. The use of DPH, a ﬂuorescent
probe that gives information of the deep core regions of the bilayer
[27], indicates that insertion is stabilized by hydrophobic interactions
between the acyl chains and the protein. However, data from TMA-
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regions of the bilayer [28], indicate that an electrostatic component
must also be involved in the interaction. Thus, the insertion of preS
domains into the bilayer would take place in two steps: a ﬁrst one
governed by electrostatic interaction between the phospholipid polar
head and the preS domain which is intrinsically basic, and a second
step driven by hydrophobic interactions which leads to the insertion
of the protein into the bilayer. When the ﬁrst step does not take place,
such as when neutral phospholipids are used, the protein does not
insert into the bilayer. Moreover, this mechanism of interactionwould
explain the differences observed with acid phospholipids at pH 7.0
and 5.0. The increment in positive charge as the pH is diminished
would favor the initial step and hence the insertion into the bilayer. It
is worth noting that these differences cannot be attributed to a
conformational change of the protein but rather to a modiﬁcation in
its ionic state since the spectroscopic properties at pH 5.0 are
coincident with those previously described at pH 7.0 [13].
As it comes about for other viral fusogenic proteins such as the
inﬂuenza virus haemagglutinin [29] or the vesicular stomatitis virus
haemagglutinin [30], preS domains were able to destabilize model
membrane systems. Thus, the interaction with negatively charged
vesicles induced their aggregation. However, these effects were not
observed when neutral phospholipid vesicles were used, indicating
that the weak interaction that takes place between the proteins and
these type of lipids, assessed by the NBD-labeling studies, was not able
to promote the vesicle–vesicle contacts necessary to form the
aggregates. Moreover, in the case of acid phospholipids, lipid mixing
studies indicate that the aggregation process leads to fusion. The
maximum degree of aggregation and lipid mixing was attained at a
protein concentration of 5–10 μM.However preS domainswere able to
disrupt the physical integrity of negatively charged phospholipid
vesicles at a considerably lower concentration (1 μM), giving rise to
the release of the aqueous contents. Electron microscopy studies
revealed that the average size of vesicles increased from 100–130 nm
to 250–430 nm after their aggregation and fusion induced by preS
domains. On the other hand, under the conditions at which OD360
diminished to values even lower than those obtained in the absence of
protein, electronmicroscopy revealed a particle size of 30–60 nm, also
lower than the size of control vesicles, indicating that preS domains
have the ability to induce the fragmentation of previously fused
liposomes. This effect has been also described for some other proteins,
as the myelin basic protein [31], and for peptides, as the WHBV
fusogenic peptide [11]. It has been suggested that membrane
tubulation and vesiculation are a consequence of insertion of the
protein into the outer leaﬂet of the bilayers, producing an excess of
area of that leaﬂet and therefore a concomitant increase in curvature
[32].
The destabilization properties mentioned above show some pH
dependence. At low protein concentrations these membrane perturb-
ing properties increased as the pH was decreased, revealing, once
again, the importance of the electrostatic interaction between the
protein and the phospholipid polar head group. This dependence
would support the hypothesis that fusion of HBV with the hepatocyte
should take place in acidic vesicles, just after a receptor-mediated
endocytosis process. However, the fact that destabilization was
produced at both pHs and that the observed differences were mostly
canceled at higher protein concentrations, would be in accordance
with a pH-independent viral infection model, since in cases of viruses
infecting cells in a pH-dependent manner no destabilizing effect at
neutral pH should be observed at all. The physiological signiﬁcance of
the increase in the fusogenic properties at acidic pH is not clear, but it
has been also observed in other viruses entering the cell by fusion
with its plasmaticmembrane at neutral pH, as it is the HIV [33]. On the
other hand, studies performed with the glycoprotein HA of the pH-
dependent inﬂuenza virus demonstrated that, in the presence of
liposomes, the decrease of pH promoted a conformational change inthe protein consisting in the exposure of the fusogenic peptide that
results in the binding of the protein to the vesicles; however, if this
protein was incubated at acidic pH in the absence of membranes, an
irreversible conformational change was produced, resulting in a
drastic binding decrease [34]. The results obtained herein with preS
domains were unchanged no matter the pH was adjusted just before
or after the addition of the phospholipid vesicles. Thus, these results
might indicate that entry of hepatitis B virus into hepatocytes would
be pH-independent.
On the other hand, interaction with liposomes also involves
structural alterations in the preS domains. CD spectra in the presence
of acidic phospholipid vesicles are indicative of a conformational
change as a consequence of the interactionwhich increased the helical
content of the protein. Although CCA method is based on globular
proteins and hence the results obtained with protein–lipid systems
cannot be taken as absolutely precise, the change in the shape of the
spectra is enough to infer such a conformational change. The increase
on helical content gives no clue on the viral fusion mechanism since
both α-helix and β-sheet have been shown to take part in the fusion
steps of other viruses [35, 36].
In summary, the results reported in this work point to the insertion
of HBV preS domains into the deep hydrophobic region of the
membrane inducing perturbing properties similar to those described
for the N-terminal S peptide [8]. Furthermore, the interaction
properties should be adscribed to the polypeptide chain and not to
the His tag since a puriﬁed preS domain which does not contain the
tag possesses similar destabilizing properties. It has been postulated
that the mechanism by which fusion proteins facilitate the formation
of fusion intermediates is a complex process involving several
membranotropic segments [37]. Moreover, the involvement of
different regions of a protein on the membrane fusion process has
indeed been proposed for various enveloped virus harboring
additional membrane fusion motifs [38], and more recently, for the
Hepatitis C virus [39, 40]. Hence, in the case of HBV, it could be
possible that different segments of the surface proteins, located in
preS domains and in the N-terminal portion of the S polypeptide,
might contribute to membrane fusion acting either simultaneously or
at different stages.
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